{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:19:24Z","timestamp":1773296364165,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There is a significant requirement for the development and acquisition of reagents that will facilitate effective diagnosis, treatment, and prevention of Lassa fever. In this regard, recombinant Lassa virus (LASV) proteins may serve as valuable tools in diverse antiviral applications. Bacterial-based systems were engineered for expression and purification of recombinant LASV nucleoprotein (NP), glycoprotein 1 (GP1), and glycoprotein 2 (GP2).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Full-length NP and the ectodomains of GP1 and GP2 were generated as maltose-binding protein (MBP) fusions in the Rosetta strains of <jats:italic>Escherichia coli<\/jats:italic> (<jats:italic>E. coli<\/jats:italic>) using pMAL-c2x vectors. Average fusion protein yields per liter of culture for MBP-NP, MBP-GP1, and MBP-GP2 were 10 mg, 9 mg, and 9 mg, respectively. Each protein was captured from cell lysates using amylose resin, cleaved with Factor Xa, and purified using size-exclusion chromatography (SEC). Fermentation cultures resulted in average yields per liter of 1.6 mg, 1.5 mg, and 0.7 mg of purified NP, GP1 and GP2, respectively. LASV-specific antibodies in human convalescent sera specifically detected each of the purified recombinant LASV proteins, highlighting their utility in diagnostic applications. In addition, mouse hyperimmune ascitic fluids (MHAF) against a panel of Old and New World arenaviruses demonstrated selective cross reactivity with LASV proteins in Western blot and enzyme-linked immunosorbent assay (ELISA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These results demonstrate the potential for developing broadly reactive immunological assays that employ all three arenaviral proteins individually and in combination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-5-74","type":"journal-article","created":{"date-parts":[[2008,6,6]],"date-time":"2008-06-06T18:13:37Z","timestamp":1212776017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance"],"prefix":"10.1186","volume":"5","author":[{"given":"Luis M","family":"Branco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Matschiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph N","family":"Fair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine","family":"Goba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl B","family":"Sampey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A","family":"Cashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randal J","family":"Schoepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B","family":"Tesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G","family":"Bausch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F","family":"Garry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary C","family":"Guttieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,6]]},"reference":[{"issue":"2","key":"423_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1586\/14760584.3.2.189","volume":"3","author":"SP Fisher-Hoch","year":"2004","unstructured":"Fisher-Hoch SP, McCormick JB: Lassa fever vaccine: A review. Expert Rev Vaccines 2004,3(2):103-111. 10.1586\/14760584.3.2.189","journal-title":"Expert Rev Vaccines"},{"key":"423_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02122438","volume":"175","author":"JB McCormick","year":"1986","unstructured":"McCormick JB: Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med Microbiol Immunol 1986, 175: 153-155. 10.1007\/BF02122438","journal-title":"Med Microbiol Immunol"},{"key":"423_CR3","first-page":"69","volume":"134","author":"JB McCormick","year":"1987","unstructured":"McCormick JB: Epidemiology and control of Lassa fever. Curr Top Microbiol Immunol 1987, 134: 69-78.","journal-title":"Curr Top Microbiol Immunol"},{"key":"423_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","volume":"311","author":"SP Fisher-Hoch","year":"1995","unstructured":"Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, McCormick JB: Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br Med J 1995, 311: 857-859.","journal-title":"Br Med J"},{"issue":"3","key":"423_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","volume":"155","author":"JB McCormick","year":"1987","unstructured":"McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES: A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 1987,155(3):437-444.","journal-title":"J Infect Dis"},{"key":"423_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliot LH, Belmont-Williams R: Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986, 314: 20-26.","journal-title":"N Engl J Med"},{"key":"423_CR7","first-page":"1635","volume-title":"Fields Virology","author":"MJ Buchmeier","year":"2001","unstructured":"Buchmeier MJ, Bowen MD, Peters CJ: Arenaviridae: The viruses and their replication. In Fields Virology. 4th edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott-Raven; 2001:1635-1668.","edition":"4"},{"issue":"22","key":"423_CR8","doi-asserted-by":"publisher","first-page":"12701","DOI":"10.1073\/pnas.221447598","volume":"A98","author":"O Lenz","year":"2001","unstructured":"Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W: The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P. Proc Natl Acad Sci U S A 2001,A98(22):12701-12705. 10.1073\/pnas.221447598","journal-title":"Proc Natl Acad Sci U S A"},{"key":"423_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-1-1","volume":"1","author":"WR Gallaher","year":"2001","unstructured":"Gallaher WR, DiSimone C, Buchmeier MJ: The viral transmembrane superfamily: Possible divergence of arenavirus and filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol 2001, 1: 1. 10.1186\/1471-2180-1-1","journal-title":"BMC Microbiol"},{"key":"423_CR10","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/JCM.38.7.2670-2677.2000","volume":"38","author":"DG Bausch","year":"2000","unstructured":"Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ, Ksiazek T: Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 2000, 38: 2670-2677.","journal-title":"J Clin Microbiol"},{"key":"423_CR11","doi-asserted-by":"crossref","unstructured":"Clegg JC, Lloyd G: Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guinea pigs against Lassa fever. Lancet 2(8552):186-188. 1987 Jul 25","DOI":"10.1016\/S0140-6736(87)90767-7"},{"issue":"1","key":"423_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0042-6822(89)90525-4","volume":"171","author":"HG Morrison","year":"1989","unstructured":"Morrison HG, Bauer SP, Lange JV, Esposito JJ, McCormick JB, Auperin DD: Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology 1989,171(1):179-188. 10.1016\/0042-6822(89)90525-4","journal-title":"Virology"},{"issue":"2","key":"423_CR13","first-page":"28","volume":"47","author":"GM Ignat'ev","year":"2002","unstructured":"Ignat'ev GM: Immunogenic and protective characteristics of recombinant Lassa virus NP protein. Vopr Virusol 2002,47(2):28-31.","journal-title":"Vopr Virusol"},{"issue":"3","key":"423_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1128\/AEM.01804-06","volume":"73","author":"H Sletta","year":"2006","unstructured":"Sletta H, Tondervik A, Hakvag S, Aune TE, Nedal A, Aune R, Evensen G, Valla S, Ellingsen TE, Brautaset T: The presence of N-terminal secretion signal sequences leads to strong stimulation of the total expression levels of three tested medically important proteins during high-cell-density cultivations of Escherichia coli . Appl Environ Microbiol 2006,73(3):906-912. (2007), Epub Dec 1 10.1128\/AEM.01804-06","journal-title":"Appl Environ Microbiol"},{"issue":"15","key":"423_CR15","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","volume":"74","author":"MD Bowen","year":"2000","unstructured":"Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, Bajani MD, Peters CJ, Nichol ST: Genetic diversity among Lassa virus strains. J Virol 2000,74(15):6992-7004. 10.1128\/JVI.74.15.6992-7004.2000","journal-title":"J Virol"},{"issue":"4","key":"423_CR16","first-page":"631","volume":"57","author":"H Wulff","year":"1979","unstructured":"Wulff H, Johnson KM: Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections. Bull World Health Organ 1979,57(4):631-5.","journal-title":"Bull World Health Organ"},{"key":"423_CR17","doi-asserted-by":"crossref","unstructured":"Wearne SJ: Factor Xa cleavage of fusion proteins. Elimination of non-specific cleavage by reversible acylation. FEBS Lett 263(1):23-6. 1990 Apr 9 10.1016\/0014-5793(90)80696-G","DOI":"10.1016\/0014-5793(90)80696-G"},{"issue":"1","key":"423_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01024906","volume":"12","author":"M He","year":"1993","unstructured":"He M, Jin L, Austen B: Specificity of Factor Xa in the cleavage of fusion proteins. J Protein Chem 1993,12(1):1-5. 10.1007\/BF01024906","journal-title":"J Protein Chem"},{"key":"423_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1099\/0022-1317-72-3-549","volume":"72","author":"SL Ruo","year":"1991","unstructured":"Ruo SL, Mitchell SW, Killey MP, Roumillat LF, Fisher-Hoch SP, McCormick JB: Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol 1991, 72: 549-555. 10.1099\/0022-1317-72-3-549","journal-title":"J Gen Virol"},{"key":"423_CR20","volume-title":"Molecular cloning: a laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. Cold Spring Harbor, Cold Spring Harbor Press; 1989."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-5-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:25:22Z","timestamp":1630459522000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-5-74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,6]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-5-74","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,6]]},"assertion":[{"value":"20 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"74"}}